coronary artery disease
Conditions
Interventions
Sponsors
Medisch Centrum Alkmaar
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: Consecutive patients scheduled for diagnostic coronary angiography or elective percutaneous coronary intervention (PCI) are screened for entry into this study. Patient are eligible for this study when it is expected that the scheduled procedure will be accomplished with a single bolus of heparin, i.e. patient undergoing a procedure with expected duration of > 1 hour will not be included in this study.
Exclusion criteria
Exclusion criteria: - Use of novel oral anticoagulants or vitamin K antagonists - Chronic use of non-steroid anti-inflammatory drugs with the exception of aspirin - Known renal insufficiency (e.g. serum creatinine level of more than 265 *mol/L (i.e. more than 3.5 mg/L)) - Liver function disorders with coagulopathies (PT >1.5N, INR >2.0 and/or thrombocyte count
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Variability in ACT measurements at different blood sampling sites at the end of coronary angiography or intervention in patients receiving pre-procedural UFH. | — |
Secondary
| Measure | Time frame |
|---|---|
| N.A. | — |
Countries
The Netherlands
Outcome results
None listed